MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 18, 2007; DOI: 10.1124/mol.107.041707


0026-895X/08/7303-995-1004$20.00
Mol Pharmacol 73:995-1004, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.041707v1
mol.107.041707v2
73/3/995    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pabbidi, R. M.
Right arrow Articles by Premkumar, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pabbidi, R. M.
Right arrow Articles by Premkumar, L. S.

Direct Role of Streptozotocin in Inducing Thermal Hyperalgesia by Enhanced Expression of Transient Receptor Potential Vanilloid 1 in Sensory Neurons

Reddy M. Pabbidi, De-Shou Cao, Arti Parihar, Mary E. Pauza, and Louis S. Premkumar

Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois (R.M.P., D.-S.C., A.P., L.S.P.); and Department of Medical Microbiology, Immunology and Cell Biology & Department of Internal Medicine/Endocrinology, Metabolism and Molecular Medicine, Southern Illinois University School of Medicine Springfield, Illinois (M.E.P.)

Streptozotocin (STZ) is a diabetogenic agent extensively used to induce diabetes and to study complications including diabetic peripheral neuropathy (DPN). While studying the influence of transient receptor potential vanilloid 1 (TRPV1) on DPN in the STZ-induced diabetic mouse model, we found that a proportion of STZ-treated mice was nondiabetic but still exhibited hyperalgesia. To understand the mechanism underlying this phenomenon, dorsal root ganglion (DRG) neurons and stably TRPV1 expressing human embryonic kidney (HEK) 293T cells were used to study the expression and function of TRPV1. Incubation of DRG neurons with STZ resulted in a significant increase in the amplitude of capsaicin-induced TRPV1-mediated current and Ca2+ influx compared with vehicle-treated sister cultures. It was also found that STZ treatment induced higher levels of reactive oxygen species, which was abolished with concomitant treatment with catalase. Treatment of cells with H2O2 mimicked the effects of STZ. Western blot analysis revealed an increase in TRPV1 protein content and phospho p38 (p-p38) mitogen-activated protein kinase (MAPK) levels in DRG of STZ-injected diabetic and nondiabetic hyperalgesic mice compared with control mice. Furthermore, in stably TRPV1-expressing HEK 293T cells, STZ treatment induced an increase in TRPV1 protein content and p-p38 MAPK levels, which was abolished with concomitant treatment with catalase or p38 MAPK inhibitor. These results reveal that STZ has a direct action on neurons and modulates the expression and function of TRPV1, a nociceptive ion channel that is responsible for inflammatory thermal pain.


Received for publication September 7, 2007.

Accepted for publication December 14, 2007.

Address correspondence to: Dr. Louis S. Premkumar, Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL 62702. E-mail: lpremkumar{at}siumed.edu




This article has been cited by other articles:


Home page
J. Neurosci.Home page
T. J. Tamsett, K. E. Picchione, and A. Bhattacharjee
NAD+ Activates KNa Channels in Dorsal Root Ganglion Neurons
J. Neurosci., April 22, 2009; 29(16): 5127 - 5134.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics